Literature DB >> 10805949

Genes implicated in hereditary breast cancer syndromes.

P N Tonin1.   

Abstract

The medical histories of breast cancer-prone families have been described for over a century. The pattern of breast cancer occurrences in these families is most consistent with an autosomal dominant mode of inheritance. The location of a gene that could explain the pattern of transmission of the breast cancer trait in families averaging early (pre-menopausal) onset of breast cancer was reported in 1990. Since then, two genes have been identified: BRCA1 and BRCA2. Germ-line mutations in these two genes confer susceptibility to breast (female and male) and ovarian cancer, and account for a significant proportion of hereditary breast cancer in two cancer syndromes: site-specific breast cancer and the breast-ovarian cancer syndrome. Other hereditary syndromes that feature breast cancer are Li-Fraumeni syndrome, Cowden disease, and ataxia telangiectasia, whose carriers have been shown to harbor germ-line mutations in TP53, PTEN, and ATM, respectively. There may be other genetic factors that contribute to hereditary breast cancer, since not all families with multiple cases of breast cancer harbor germ-line BRCA1 or BRCA2 mutations. Host factors (such as lifestyle choices) and other genes may modulate risk of breast cancer in mutation carriers. Copyright 2000 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10805949     DOI: 10.1002/(sici)1098-2388(200006)18:4<281::aid-ssu2>3.0.co;2-q

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  7 in total

1.  Genetic determination of susceptibility to estrogen-induced mammary cancer in the ACI rat: mapping of Emca1 and Emca2 to chromosomes 5 and 18.

Authors:  Karen A Gould; Martin Tochacek; Beverly S Schaffer; Tanya M Reindl; Clare R Murrin; Cynthia M Lachel; Eric A VanderWoude; Karen L Pennington; Lisa A Flood; Kimberly K Bynote; Jane L Meza; Michael A Newton; James D Shull
Journal:  Genetics       Date:  2004-12       Impact factor: 4.562

2.  Important considerations for recruiting women to cancer genetics studies in Puerto Rico.

Authors:  Euna M August; Gwen P Quinn; Rossybelle Perales; Zuheily Closser; Julie Dutil; Marieva Puig; Susan T Vadaparampil
Journal:  J Cancer Educ       Date:  2012-03       Impact factor: 2.037

Review 3.  Measurement of psychological factors associated with genetic testing for hereditary breast, ovarian and colon cancers.

Authors:  Susan T Vadaparampil; Mary Ropka; Michael E Stefanek
Journal:  Fam Cancer       Date:  2005       Impact factor: 2.375

4.  Awareness, perceptions, and provider recommendation related to genetic testing for hereditary breast cancer risk among at-risk Hispanic women: similarities and variations by sub-ethnicity.

Authors:  Susan T Vadaparampil; Jessica McIntyre; Gwendolyn P Quinn
Journal:  J Genet Couns       Date:  2010-08-27       Impact factor: 2.537

5.  A polymorphic variant in human MDM4 associates with accelerated age of onset of estrogen receptor negative breast cancer.

Authors:  Diptee A Kulkarni; Alexei Vazquez; Bruce G Haffty; Elisa V Bandera; Wenwei Hu; Yvonne Y Sun; Deborah L Toppmeyer; Arnold J Levine; Kim M Hirshfield
Journal:  Carcinogenesis       Date:  2009-09-16       Impact factor: 4.944

Review 6.  Stress and breast cancer: from epidemiology to molecular biology.

Authors:  Lilia Antonova; Kristan Aronson; Christopher R Mueller
Journal:  Breast Cancer Res       Date:  2011-04-21       Impact factor: 6.466

7.  Association of striking life events with primary breast cancer in 265 Chinese women: a case-control study.

Authors:  Yan Lin; Shengsheng Wang; Xiaohui Zhang; Changjun Wang; Guangliang Shan; Yidong Zhou; Feng Mao; Jinghong Guan; Xin Huang; Ying Zhong; Qiang Sun
Journal:  Oncotarget       Date:  2017-06-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.